Butyrate and trichostatin a effects on the proliferation/differentiation of human intestinal epithelial cells: Induction of cyclin D3 and p21 expression

Gut

Volumn 46, Issue 4, 2000, Pages 507-514

  Siavoshian, S ^a   Segain, J P ^a   Kornprobst, M ^a   Bonnet, C ^b   Cherbut, C ^b   Galmiche, J P ^a   Blottiere H M ^a,b  

^a HÔTEL DIEU   (France)

^b CEMAGREF   (France)

Author keywords

Butyrate; Colonic epithelial cells; Cyclin D; Histone acetylation; p21; Trichostatin A

Indexed keywords

BUTYRIC ACID; CYCLIN D3; HISTONE DEACETYLASE; HISTONE H4; PROTEIN P21; TRICHOSTATIN A;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DRUG MECHANISM; FERMENTATION; HUMAN; HUMAN CELL; INTESTINE CELL; INTESTINE EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYLATION; BUTYRATES; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CYCLIN D1; CYCLINS; ENZYME INHIBITORS; EPITHELIAL CELLS; GENE EXPRESSION; HISTONE DEACETYLASES; HISTONES; HT29 CELLS; HUMANS; HYDROXAMIC ACIDS; INTESTINAL MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0034105047     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.4.507     Document Type: Article

References (46)

1. 1 Cummings JH, Pomare EW, Branch WJ, et al. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987;28:1221-7.
2. 2 Chung YS, Song IS, Erickson RH, et al. Effect of growth and sodium butyrate on brush border membrane-associated hydrolases in human colorectal cancer cell lines. Cancer Res 1985;45:2976-82.
3. 3 Kruh J, Tichonicky L, Defer N. Effect of butyrate on gene expression. In: Binder HJ, Cummings J, Soergel KH, eds. Short chain fatty acids. Dordrecht: Kluwer, 1994:135-47.
4. 4 Perrin P, Cassagnau E, Burg C, et al. An interleukin 2/sodium butyrate combination as immunotherapy of rat colon cancer peritoneal carcinomatosis. Gastroenterology 1994;107:1697-708.
5. 5 Hague A, Elder DJE, Hicks DJ, et al. Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer 1995;60:400-6.
6. 6 Darzynkiewicz Z, Traganos F, Xue SB, et al. Effect of n-butyrate on cell cycle progression and in situ chromatin structure of L1210 cells. Exp Cell Res 1981;136:279-93.
7. 7 Siavoshian S, Blottière HM, Cherbut C, et al. Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase expression in HT-29 colonic epithelial cells. Biochem Biophys Res Commun 1997;232:169-72.
8. 8 Riggs MG, Whittaker RG, Neumann J, et al. n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells. Nature 1977;268:462-4.
9. 9 Cousens LS, Gallwitz D, Alberts BM. Different accessibilities in chromatin to histone acetylase. J Biol Chem 1979;254:1716-23.
10. 10 Norton VG, Imai BS, Yau P, et al. Histone acetylation reduces nucleosome core particle linking number change. Cell 1989;57:449-57.
11. 11 Csordas A. On the biological role of histone acetylation. Biochem J 1990;265:23-38.
12. 12 Taunton J, Hassig CA, Schreiber SL. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 1996; 272:408-11.
13. 13 Yoshida M, Kijima M, Akita M, Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 1990;265:17174-9.
14. 14 Yoshida M, Nomura S, Beppu T. Effects of trichostatin on differentiation of murine erythroleukemia cells. Cancer Res 1987;47:3688-91.
15. 15 Yoshida M, Beppu T. Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A. Exp Cell Res 1988;117:122-31.
16. 16 Dion LD, Goldsmith KT, Tang D, et al. Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase. Virology 1997;231:201-9.
17. 17 Huang N, Katz JP, Martin DR, et al. Inhibition of IL-8 gene expression in Caco-2 cells by compounds which induce histone hyperacetylation. Cytokine 1997;9:27-36.
18. WAF1-CIP1 in human breast cancer. Int J Cancer 1995; 63:584-91.
19. 19 Brasaemle DL, Attie AD. Microelisa reader quantitation of fixed, stained, solubilized cells in microtitre dishes. Biotechniques 1988;6:418-19.
20. 20 Harb J, Vavasseur F, Chadeneau C, et al. Expression of alkaline phosphatase in murine lymphoma cells. Biochem Biophys Res Commun 1991;177:125-33.
21. 21 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
22. 22 Whitehead RH, Young GP, Bhathal PS. Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM 1215). Gut 1986;27:1457-63.
23. 23 Gamet L, Daviaud D, Denis-Pouxviel C, et al. Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT-29. Int J Cancer 1992;52: 286-9.
24. 24 Siavoshian S, Blottière HM, Le Foll E, et al. Comparison of the effect of different short chain fatty acids on the growth and differentiation of human colonic carcinoma cell lines in vitro. Cell Biol Int 1997;21:281-7.
25. 25 McBain JA, Eastman A, Nobel CS, et al. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem Pharmacol 1997;53: 1357-68.
26. 26 Nakano K, Mizuno T, Sowa Y, et al. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J Biol Chem 1997;272:22199-206.
27. 27 Heerdt BG, Houston MA, Augenlicht LH. A direct link between core histone acetylation and transcriptionally active chromatin. Cell Growth Differ 1997;8:523-32.
28. 28 Lallemand F, Courilleau D, Sabbah M, et al. Direct inhibition of the expression of cyclin D1 gene by sodium butyrate. Biochem Biophys Res Commun 1996;229:163-9.
29. 29 Kiess M, Gill RM, Hamel PA. Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene 1995;10:159-66.
30. 30 Jiang H, Lin J, Su ZZ, et al. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 1994;9:3397-406.
31. 31 Steinman RA, Hoffman B, Iro A, et al. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 1994;9: 3389-96.
32. 32 Hodin RA, Meng S, Archer S, et al. Cellular growth state differentially regulates enterocyte gene expression in butyrate-treated HT-29 cells. Cell Growth Differ 1996;7: 647-53.
33. 33 Goldberg Y, Nassif II, Pittas A, et al. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins. Oncogene 1996;12:893-901.
34. 34 Harper JW, Elledge SJ, Keyomarsi K, et al. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 1995;6: 387-400.
35. 35 Sowa Y, Orita T, Minamikawa S, et al. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Biochem Biophys Res Commun 1997;241:142-50.
36. 36 Blottière HM, Zennadi R, Grégoire M, et al. Analysis of the relationship between stage of differentiation and NK/LAK susceptibility of colon carcinoma cells. Int J Cancer 1993;53:409-17.
37. 37 Park C, Chamberlin ME, Pan CJ, et al. Differential expression and butyrate response of human alkaline phosphatase genes are mediated by upstream DNA elements Biochemistry 1996;35:9807-14.
38. 38 Bohm SK, Gum JR, Erickson RH, et al. Human dipeptidyl peptidase IV gene promoter: tissue-specific regulation from a TATA-less GC-rich sequence characteristic of a housekeeping gene promoter. Biochem J 1995;311:835-43.
39. 39 Arts J, Lansink M, Grimbergen J, et al. Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation. Biochem J 1995;310:171-6.
40. 40 Whitlock JP Jr, Galeazzi D, Schulman H. Acetylation and calcium-dependent phosphorylation of histone H3 in nuclei from butyrate-treated HeLa cells. J Biol Chem 1983; 258:1299-304.
41. 41 Parker MI, De Haan JB, Gevers W. DNA hypermethylation in sodium butyrate-treated WI-38 fibroblasts. J Biol Chem 1986;261:2786-90.
42. 42 Cuisset L, Tichonicky L, Jaffray P, et al. The effects of sodium butyrate on transcription are mediated through activation of a protein phosphatase. J Biol Chem 1997;272: 24148-53.
43. WAF1-CIP1 expression in normal and neoplastic tissues. Cancer Res 1995;55:2910-19.
44. WAF1 CIP1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression. Pathol Int 1997;47;470-7.
45. 45 Li YJ, Laurent-Puig P, Salmon RJ, et al. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Oncogene 1995;10:599-601.
46. 46 Shiohara M, El-Deiry WS, Wada M, et al. Absence of WAF1 mutations in a variety of human malignancies. Blood 1994; 84:3781-4.